Why generic AI fails on local clinical reality

There is a comforting assumption in healthcare technology right now: that a sufficiently powerful general-purpose model, given a good prompt, can handle clinical work almost anywhere. The leaderboard scores seem to back it up. But a leaderboard measures a model on average tasks, and a hospital is not an average task. It is a very specific place, with its own language, its own coding sets, and its own rulebook for what gets paid. The gap between 'smart in general' and 'competent here' is where most clinical AI quietly fails.

To see why, it helps to think about what a general model has actually read. It learned from a vast slice of the open internet — overwhelmingly English, overwhelmingly generic. The dense, local material that governs real clinical work — a country's reimbursement clauses, its national coding conventions, the way patients in a particular region actually describe their symptoms — is barely present in that diet, if at all. So when you ask such a model whether a procedure is reimbursable under a specific national rule, it does what models do when they are out of their depth: it produces a fluent, confident answer that may be quietly wrong.

That is not hypothetical. In our internal evaluation, comparing a localized clinical model against leading general-purpose models on the same tasks, the gap was starkest on exactly the local problems. On reimbursement-rule decisions the localized model scored 91% while the general models clustered between 65% and 75%. On understanding regional, everyday descriptions of symptoms it reached 88%, where the generic systems fell to between 49% and 63%. And on the most dangerous failure mode — inventing or misattributing a regulatory clause — the generic models did so several times more often than the localized one's 0.3%.

Closing that gap is an engineering problem with a fairly clear shape. You teach the model the local clinical language through continued pre-training, the way you would immerse someone in a country rather than hand them a phrasebook. You add specialty knowledge in modular pieces so it can reason like a coder, a cardiologist, or a reimbursement specialist as needed. And you ground its answers in retrieval, so it cites a real, current source instead of trusting its own memory. None of this is exotic — and, crucially, none of it is specific to one country.

That last point is what makes this more than a one-market story. The reason a localized model wins is not a secret sauce that only works in Türkiye; it is a method you can point at any market's language, codes and rules. Generic intelligence gets you in the door. Local competence is what lets the work actually be trusted, billed and acted on.

A fair caution: these figures come from internal evaluation on synthetic, anonymized data, and the comparison systems were kept anonymous and run under identical conditions. They are a strong indicator of where localized models pull ahead — not a clinical guarantee, and not a substitute for real-world validation, which is underway. The point was never to win a benchmark. It was to show that 'fit' is a measurable thing, and that generic and local are not the same.